NCT00901758View on ClinicalTrials.gov

Intravenous (IV) Nitroglycerin for Versions in Multiparous Women

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

October 31, 2006

Study Completion Date

February 29, 2008

Conditions
Breech PresentationPregnancy Complication
Interventions
DRUG

IV Nitroglycerin

IV injection, initial does of 1mL, with further doses of 1-3mL, up to a recommended maximum of 10mL.

DRUG

Normal saline

IV injection, initial does of 1mL, with further doses of 1-3mL, up to a recommended maximum of 10mL

Trial Locations (3)

T2N 4J8

Foothills Medical Centre, Calgary

Unknown

Peter Lougheed Centre, Calgary

Rockyview Hospital, Calgary

All Listed Sponsors
lead

University of Calgary

OTHER

NCT00901758 - Intravenous (IV) Nitroglycerin for Versions in Multiparous Women | Biotech Hunter | Biotech Hunter